ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
아목시실린 시장 규모는 향후 수년간 안정된 성장이 예상됩니다. 2029년에 CAGR은 3.2%를 나타낼 것으로 예측되고 55억 6,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 신기능 장애 증가, 하부 호흡기 감염 유병률, 피부 감염 증가, 하부 호흡기 감염 사례 증가, 세균 감염 유병률 상승 등에 기인할 수 있습니다. 예측 기간의 주요 동향에는 제네릭 아목시실린 수요 증가, 복합 요법 주력, 프로바이오틱스와 면역요법에 대한 관심, 항생제 수요 증가, 그리고 고급 의료 시설 확대 등이 포함됩니다.
향후 5년간 3.2% 성장 전망은 이 시장에 대한 이전 추정치 대비 0.2% 소폭 하향 조정된 수치입니다. 이 하향 조정은 주로 미국과 타국 간 관세 영향 때문입니다. 관세 장벽은 인도와 중국에서 공급원인 아목시실린 원료의약품(API) 및 완제 의약품의 비용을 증가시켜 항생제 접근성을 감축하고 일차 진료 처방 비용을 상승시킴으로써 미국 시장에 부정적 영향을 미칠 것으로 예상됩니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 효과가 더욱 광범위하게 나타날 것입니다.
감염병의 증가하는 유병률은 향후 몇 년간 아목시실린 시장 성장을 촉진할 것으로 예상됩니다. 박테리아, 바이러스, 곰팡이 또는 기생충과 같은 병원성 미생물에 의해 발생하는 감염병은 전 세계 여행, 항생제 내성, 질병 매개체에 영향을 미치는 기후 변화, 인구 밀도 증가 등의 요인으로 인해 더욱 흔해지고 있습니다. 아목시실린은 박테리아 세포벽 합성을 표적으로 하여 박테리아 세포 사멸을 유도함으로써 이러한 감염병 치료에 효과적인 것으로 알려져 있습니다. 광범위한 항균 스펙트럼, 빠른 흡수율, 다른 항생제와의 시너지 효과로 인해 다양한 세균 감염에 유연하고 효과적인 치료제로 활용됩니다. 예를 들어, 2023년 1월 미국 국립보건원(NIH) 보고에 따르면 요로감염증은 미국 응급실 방문 주요 원인 중 7위를 차지했으며, 연간 100만 건 이상의 방문이 기록될 것으로 예상됩니다. 이 중 22%(22만 건)는 복잡성 요로감염으로 분류되었으며, 매년 약 10만 건이 입원으로 이어졌습니다. 결과적으로 감염병의 증가하는 유병률은 아목시실린 시장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 아목시실린 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 아목시실린 시장 : 성장률 분석
세계의 아목시실린 시장 실적 : 규모와 성장(2019-2024년)
세계의 아목시실린 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 아목시실린 : 총 잠재시장 규모(TAM)
제6장 시장 세분화
세계의 아목시실린 시장 : 약제 클래스별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
페니실린
세팔로스포린
테트라사이클린
마크로라이드
술폰아미드
세계의 아목시실린 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
단제요법
병용 요법
세계의 아목시실린 시장 : 형태별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
태블릿
캡슐
서스펜션
시럽
분말
세계의 아목시실린 시장 : 감염 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
피부 감염
이비인후 감염
위 감염
폐 감염
요로 감염(UTI)
폐렴
기관지염
임질
세계의 아목시실린 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 아목시실린 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 아목시실린 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
아목시실린 시장 : 경쟁 구도
아목시실린 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
AstraZeneca Plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
GlaxoSmithKline Plc : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Merck KGaA
Teva Pharmaceutical Industries Ltd.
Alkem Laboratories Ltd.
Sun Pharmaceutical Industries Ltd.
CSPC Pharmaceutical Group Limited
Torrent Pharmaceuticals GmbH
Aurobindo Pharma Limited
Hikma Pharmaceuticals PLC
Intas Pharmaceuticals Ltd.
Lupin Limited
Daewoong Pharmaceutical Co. Ltd.
Centrient Pharmaceuticals
Wockhardt Limited
Ranbaxy Laboratories Ltd.
Atman Pharmaceuticals
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
아목시실린 시장(2029년) : 새로운 기회를 제공하는 국가
아목시실린 시장(2029년) : 새로운 기회를 제공하는 부문
아목시실린 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Amoxicillin, a member of the penicillin group, is a broad-spectrum antibiotic used for treating a wide range of bacterial infections. Its mechanism involves inhibiting bacterial growth by preventing the formation of cell walls. This effectively combats infections including respiratory tract infections, urinary tract infections, skin infections, and certain types of bacterial endocarditis.
Amoxicillin belongs to the main drug classes of antibiotics such as penicillins, cephalosporins, tetracyclines, macrolides, and sulfonamides. Penicillins are derived from the Penicillium mold and share a core structure. The drug is available in various formulations including tablets, capsules, suspensions, syrup, and powder. It is used for treating infections such as skin infections, ear, nose, and throat infections, gastrointestinal infections, pulmonary infections, urinary tract infections (UTIs), pneumonia, bronchitis, and gonorrhea. These treatments are utilized across different settings including hospitals, homecare, specialty clinics, and other healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The amoxicillin market research report is one of a series of new reports from The Business Research Company that provides amoxicillin market statistics, including amoxicillin industry global market size, regional shares, competitors with amoxicillin market share, detailed amoxicillin market segments, market trends and opportunities, and any further data you may need to thrive in the amoxicillin industry. This amoxicillin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The amoxicillin market size has grown steadily in recent years. It will grow from $4.74 billion in 2024 to $4.9 billion in 2025 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to an increased understanding of antibiotics, a higher pace of research activities and developments, increased cases of cardiovascular diseases, increased demand for amoxicillin in the treatment of urinary tract infections, rise in the aging population.
The amoxicillin market size is expected to see steady growth in the next few years. It will grow to $5.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.2%. The growth in the forecast period can be attributed to growing impaired renal function, prevalence of lower respiratory infections, increasing skin infections, growing cases of lower respiratory tract infections, and rising prevalence of bacterial infections. Major trends in the forecast period include demand for generic amoxicillin, focus on combination therapies, interest in probiotics and immunotherapy, demand for antibiotics, and advanced healthcare facilities.
The forecast of 3.2% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of amoxicillin Active Pharmaceutical Ingredient(API) and finished dosage forms sourced from India and China, thereby reducing antibiotic accessibility and elevating primary care prescription expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising prevalence of infectious diseases is anticipated to drive the growth of the amoxicillin market in the coming years. Infectious diseases, caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, are becoming more common due to factors such as global travel, antimicrobial resistance, climate change affecting disease vectors, and higher population density. Amoxicillin is effective in treating these diseases by targeting bacterial cell wall synthesis, leading to bacterial cell death. Its broad-spectrum activity, rapid absorption, and ability to work synergistically with other antibiotics make it a versatile and effective treatment for various bacterial infections. For example, in January 2023, the National Institute of Health reported that urinary tract infections ranked seventh among the leading reasons for emergency department visits in the US, accounting for over 1 million visits annually. Of these, 22% (220,000) were classified as complicated UTIs, with approximately 100,000 cases resulting in hospital admissions each year. Consequently, the increasing prevalence of infectious diseases is fueling the growth of the amoxicillin market.
The increase in healthcare expenditure is expected to drive the growth of the amoxicillin market in the future. Healthcare expenditure refers to the total money spent on healthcare goods and services, including medical treatments, medications, hospitalizations, and preventive care, within a specific period. This expenditure reflects the overall cost of healthcare provision within a population. The rising healthcare expenditures are due to the increasing costs of advanced medical technologies, aging populations, and the prevalence of chronic diseases. Increased healthcare expenditure benefits amoxicillin by ensuring wider accessibility and availability, leading to higher prescription rates and improved patient outcomes. Enhanced funding also supports research and development, potentially leading to better formulations and broader usage of the antibiotic. For example, in January 2024, the National Institutes of Health reported that healthcare expenditure in the US rose by 4.1% in 2022 to reach $4.5 trillion, marking a faster growth rate compared to the 3.2% increase observed in 2021. Thus, the increase in healthcare expenditure is driving the growth of the amoxicillin market.
Major companies in the amoxicillin market are developing innovative drugs, such as reformulated versions of vonoprazan tablets, to enhance the treatment of Helicobacter pylori infections and improve patient outcomes. Vonoprazan is a novel potassium-competitive acid blocker (PCAB), a new class of acid suppressant medication. For example, in May 2022, Phathom Pharmaceuticals, a US-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for VOQUEZNA TRIPLE PAK (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA DUAL PAK (vonoprazan, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection in adults. These treatment regimens include antibiotics conveniently packaged with vonoprazan, a novel potassium-competitive acid blocker (PCAB), marking the first innovative acid suppressant from a new drug class approved in the U.S. in over 30 years.
North America was the largest region in the amoxicillin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amoxicillin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the amoxicillin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The amoxicillin market consists of sales of oral formulations, liquid formulations, extended-release tablets, and specialty products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Amoxicillin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on amoxicillin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for amoxicillin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The amoxicillin market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Class: Penicillin; Cephalosporin; Tetracycline; Macrolides; Sulfonamides
2) By Therapy Type: Monotherapy; Combinational Therapy
3) By Form: Tablets; Capsule; Suspensions; Syrup; Powder
4) By Infection Type: Skin Infections; Ear, Nose And Throat Infections; Stomach Infections; Lungs Infections; Urinary tract infections (UTI); Pneumonia; Bronchitis; Gonorrhea
5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Amoxicillin Market Characteristics
3. Amoxicillin Market Trends And Strategies
4. Amoxicillin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Amoxicillin Growth Analysis And Strategic Analysis Framework
5.1. Global Amoxicillin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Amoxicillin Market Growth Rate Analysis
5.4. Global Amoxicillin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Amoxicillin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Amoxicillin Total Addressable Market (TAM)
6. Amoxicillin Market Segmentation
6.1. Global Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Penicillin
Cephalosporin
Tetracycline
Macrolides
Sulfonamides
6.2. Global Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monotherapy
Combinational Therapy
6.3. Global Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsule
Suspensions
Syrup
Powder
6.4. Global Amoxicillin Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Skin Infections
Ear, Nose And Throat Infections
Stomach Infections
Lungs Infections
Urinary tract infections (UTI)
Pneumonia
Bronchitis
Gonorrhea
6.5. Global Amoxicillin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Specialty Clinics
Other End Users
6.6. Global Amoxicillin Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Penicillin G
Penicillin V
Extended-Spectrum Penicillins (Amoxicillin)
Beta-Lactam Antibiotics
6.7. Global Amoxicillin Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First-Generation Cephalosporins (Cephalexin)
Second-Generation Cephalosporins (Cefuroxime)
Third-Generation Cephalosporins (Ceftriaxone)
Fourth-Generation Cephalosporins (Cefepime)
6.8. Global Amoxicillin Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Doxycycline
Minocycline
Tetracycline Hydrochloride
6.9. Global Amoxicillin Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Azithromycin
Erythromycin
Clarithromycin
6.10. Global Amoxicillin Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sulfamethoxazole
Sulfadiazine
Sulfasalazine
Trimethoprim-Sulfamethoxazole Combination
7. Amoxicillin Market Regional And Country Analysis
7.1. Global Amoxicillin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Amoxicillin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Amoxicillin Market
8.1. Asia-Pacific Amoxicillin Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Amoxicillin Market
9.1. China Amoxicillin Market Overview
9.2. China Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Amoxicillin Market
10.1. India Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Amoxicillin Market
11.1. Japan Amoxicillin Market Overview
11.2. Japan Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Amoxicillin Market
12.1. Australia Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Amoxicillin Market
13.1. Indonesia Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Amoxicillin Market
14.1. South Korea Amoxicillin Market Overview
14.2. South Korea Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Amoxicillin Market
15.1. Western Europe Amoxicillin Market Overview
15.2. Western Europe Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Amoxicillin Market
16.1. UK Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Amoxicillin Market
17.1. Germany Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Amoxicillin Market
18.1. France Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Amoxicillin Market
19.1. Italy Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Amoxicillin Market
20.1. Spain Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Amoxicillin Market
21.1. Eastern Europe Amoxicillin Market Overview
21.2. Eastern Europe Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Amoxicillin Market
22.1. Russia Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Amoxicillin Market
23.1. North America Amoxicillin Market Overview
23.2. North America Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Amoxicillin Market
24.1. USA Amoxicillin Market Overview
24.2. USA Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Amoxicillin Market
25.1. Canada Amoxicillin Market Overview
25.2. Canada Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Amoxicillin Market
26.1. South America Amoxicillin Market Overview
26.2. South America Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Amoxicillin Market
27.1. Brazil Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Amoxicillin Market
28.1. Middle East Amoxicillin Market Overview
28.2. Middle East Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Amoxicillin Market
29.1. Africa Amoxicillin Market Overview
29.2. Africa Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Amoxicillin Market Competitive Landscape And Company Profiles
30.1. Amoxicillin Market Competitive Landscape
30.2. Amoxicillin Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
31. Amoxicillin Market Other Major And Innovative Companies
31.1. Merck KGaA
31.2. Teva Pharmaceutical Industries Ltd.
31.3. Alkem Laboratories Ltd.
31.4. Sun Pharmaceutical Industries Ltd.
31.5. CSPC Pharmaceutical Group Limited
31.6. Torrent Pharmaceuticals GmbH
31.7. Aurobindo Pharma Limited
31.8. Hikma Pharmaceuticals PLC
31.9. Intas Pharmaceuticals Ltd.
31.10. Lupin Limited
31.11. Daewoong Pharmaceutical Co. Ltd.
31.12. Centrient Pharmaceuticals
31.13. Wockhardt Limited
31.14. Ranbaxy Laboratories Ltd.
31.15. Atman Pharmaceuticals
32. Global Amoxicillin Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Amoxicillin Market
34. Recent Developments In The Amoxicillin Market
35. Amoxicillin Market High Potential Countries, Segments and Strategies
35.1 Amoxicillin Market In 2029 - Countries Offering Most New Opportunities
35.2 Amoxicillin Market In 2029 - Segments Offering Most New Opportunities
35.3 Amoxicillin Market In 2029 - Growth Strategies
